DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
复制标题
DOI:
10.1016/j.jaut.2017.03.001
复制
发表时间:
2017-07
影响因子:
12.8
通讯作者:
Morse HC 3rd
中科院分区:
文献类型:
--
作者:
Sakai T;Miyazaki T;Shin DM;Kim YS;Qi CF;Fariss R;Munasinghe J;Wang H;Kovalchuk AL;Kothari PH;Fermaintt CS;Atkinson JP;Perrino FW;Yan N;Morse HC 3rd
TREX1/DNASE III, the most abundant 3′-5′ DNA exonuclease in mammalian cells, is tail-anchored on the endoplasmic reticulum (ER). Mutations at the N-terminus affecting TREX1 DNase activity are associated with autoimmune and inflammatory conditions such as Aicardi-Goutières syndrome (AGS). Mutations in the C-terminus of TREX1 cause loss of localization to the ER and dysregulation of oligosacchryltransferase (OST) activity, and are associated with retinal vasculopathy with cerebral leukodystrophy (RVCL) and in some cases with systemic lupus erythematosus (SLE). Here we investigate mice with conditional expression of the most common RVCL mutation, V235fs, and another mouse expressing a conditional C-terminal mutation, D272fs, associated with a case of human SLE. Mice homozygous for either mutant allele express the encoded human TREX1 truncations without endogenous mouse TREX1, and both remain DNase active in tissues. The two mouse strains are similar phenotypically without major signs of retinal, cerebral or renal disease but exhibit striking elevations of autoantibodies in the serum. The broad range of autoantibodies is primarily against non-nuclear antigens, in sharp contrast to the predominantly DNA-related autoantibodies produced by a TREX1-D18N mouse that specifically lacks DNase activity. We also found that treatment with an OST inhibitor, aclacinomycin, rapidly suppressed autoantibody production in the TREX1 frame-shift mutant mice. Together, our study presents two new mouse models based on TREX1 frame-shift mutations with a unique set of serologic autoimmune-like phenotypes.
登录
查看更多内容
影响因子:
64.5
作者:
Stetson DB;Ko JS;Heidmann T;Medzhitov R
通讯作者:
Medzhitov R
影响因子:
32.4
作者:
Gall A;Treuting P;Elkon KB;Loo YM;Gale M Jr;Barber GN;Stetson DB
通讯作者:
Stetson DB
DOI:
10.1084/jem.20061041
发表时间:
2006-10-30
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ha SA;Tsuji M;Suzuki K;Meek B;Yasuda N;Kaisho T;Fagarasan S
通讯作者:
Fagarasan S
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
11.2
作者:
Shin DM;Shaffer DJ;Wang H;Roopenian DC;Morse HC 3rd
通讯作者:
Morse HC 3rd